IFM Investors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-20,987
Closed -$532K – 642
2022
Q3
$532K Hold
20,987
– – 0.01% 605
2022
Q2
$697K Hold
20,987
– – 0.01% 594
2022
Q1
$1.51M Buy
20,987
+3,364
+19% +$242K 0.02% 532
2021
Q4
$1.62M Hold
17,623
– – 0.03% 517
2021
Q3
$2.23M Sell
17,623
-256
-1% -$37.3K 0.05% 404
2021
Q2
$2.97M Buy
17,879
+5,176
+41% +$839K 0.06% 314
2021
Q1
$2.31M Buy
12,703
+1,795
+16% +$416K 0.06% 319
2020
Q4
$2.18M Buy
10,908
+5,141
+89% +$1.05M 0.07% 284
2020
Q3
$1.26M Buy
5,767
+499
+9% +$106K 0.05% 336
2020
Q2
$1M Buy
+5,268
New +$923K 0.05% 348

Other funds holding TDOC

IFM Investors's TDOC Position: Q4 2022 in Review

IFM Investors sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 20,987 shares — an estimated $532K sold.

IFM Investors first reported a position in TDOC in Q2 2020 and held it in 10 quarters. The position peaked at $2.97M in Q2 2021. 443 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • IFM Investors reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • IFM Investors sold 20,987 Teladoc Health shares in Q4 2022, an estimated $532K.
  • IFM Investors first reported a position in Teladoc Health in Q2 2020 and held it in 10 quarters.
  • IFM Investors's Teladoc Health position peaked at $2.97M in Q2 2021.
  • 443 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on IFM Investors's 13F filing for Q4 2022, filed 14 Feb 2023.